Editas Medicine to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Aug 27, 2025
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that management will participate in the following upcoming investor conferences in September:
Read more at globenewswire.com
